services in biometrical planning, data management and statistical analysis (IAS GmbH)
90
Structured Review
IAS GmbH
services in biometrical planning, data management and statistical analysis
Services In Biometrical Planning, Data Management And Statistical Analysis, supplied by IAS GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/statistics+data+analysis/services+in+biometrical+planning++data+management+and+statistical+analysis/pmc04891394-161-12-0
Average 90 stars, based on 1 article reviews
Services In Biometrical Planning, Data Management And Statistical Analysis, supplied by IAS GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/statistics+data+analysis/services+in+biometrical+planning++data+management+and+statistical+analysis/pmc04891394-161-12-0
Average 90 stars, based on 1 article reviews
services in biometrical planning, data management and statistical analysis - by Bioz Stars,
2026-11
90/100 stars
Images
Related Articles
other:Article Title: Treatment Satisfaction During Routine Treatment with the SQ®-Standardised Grass Allergy Immunotherapy Tablet: A Non-interventional Observational Study Article Snippet: Article Title: Health-Related Quality of Life During Routine Treatment with the SQ-Standardised Grass Allergy Immunotherapy Tablet: A Non-Interventional Observational Study Article Snippet: Article Title: Immunologic effect and tolerability of intra-seasonal subcutaneous immunotherapy with an 8-day up-dosing schedule to 10,000 standardized quality-units: a double-blind, randomized, placebo-controlled trial. Article Snippet: Immunologic Effect and Tolerability of Intra-Seasonal Subcutaneous Immunotherapy With an 8-Day Up-Dosing Schedule to 10,000 Standardized Quality-Units: A DoubleBlind, Randomized, Placebo-Controlled Trial Oliver Pfaar, MD; Hendrik Wolf, PhD; Ludger Klimek, MD; Jörg Schnitker, PhD; and ike Wüstenberg, MD Center for Rhinology and Allergology, Department of Otorhinolaryngology, Head and Neck Surgery, niversity Hospital Mannheim, Wiesbaden, Germany; ALK Arzneimittel GmbH, Wedel, Germany; and Institut für angewandte Statistik GmbH, Bielefeld, Germany Article Title: Safety and Tolerability of an Intra-seasonal Initiation of the SQ-Standardised Grass Allergy Immunotherapy Tablet: A Non-interventional Observational Study Investigating the Feasibility During Routine Administration Article Snippet: Article Title: Safety and tolerability of the standardized quality house dust mite sublingual immunotherapy tablet in real life: A noninterventional, open-label study. Article Snippet: House dust mites (HDMs) are a major source of indoor allergens and an important factor for triggering airway diseases such as allergic rhinitis (AR) and allergic asthma (AA).. The worldwide prevalence of sensitization to HDM is high and is estimated to affect 1% to 2% of the global population.. In Germany, about 16% of the adult population is sensitized to HDMs. |